Concept information
...
glycolipid
glycosphingolipid
neolacto-series glycosphingolipid
n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide
...
glycolipid
glycosphingolipid
neolacto-series glycosphingolipid
n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide
...
sphingolipid
glycosphingolipid
neolacto-series glycosphingolipid
n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide
...
sphingolipid
glycosphingolipid
neolacto-series glycosphingolipid
n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide
...
sphingolipid
glycosphingolipid
neolacto-series glycosphingolipid
n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide
Preferred term
n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:1(4e))
Type
-
http://www.irandoc.ac.ir/onto/irandoc-meta/Concept
charge
- 0
formula
- C113H192N5O71R
mass
- 2756.729
monoisotopicmass
- 2755.15671
smiles
- O(C[C@@H]([C@@H](/C=C/CCCCCCCCCCCCCCC)O)NC(=O)*)[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O[C@H]6[C@@H]([C@H]([C@H]([C@H](O6)CO)O)O[C@@H]7[C@@H]([C@H]([C@H]([C@H](O7)CO)O)O)O)O[C@H]8[C@H]([C@@H]([C@@H]([C@@H](O8)C)O)O)O)O)NC(=O)C)O)O[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O[C@H]%10[C@@H]([C@H]([C@H]([C@H](O%10)CO)O)O[C@H]%11[C@@H]([C@H]([C@@H]([C@H](O%11)CO)O[C@H]%12[C@@H]([C@H]([C@H]([C@H](O%12)CO)O)O[C@@H]%13[C@@H]([C@H]([C@H]([C@H](O%13)CO)O)O)O)O[C@H]%14[C@H]([C@@H]([C@@H]([C@@H](O%14)C)O)O)O)O)NC(=O)C)O)O)NC(=O)C)O)O)NC(=O)C)O)O)O
subset
- 2_STAR
synonym RELATED
- alpha-D-GalNAc-(1->3)-[alpha-L-Fuc-(1->2)]-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-[alpha-D-GalNAc-(1->3)-(alpha-L-Fuc-(1->2))-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)]-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d20:1(4E))
- a neolactoside VIII(3)-alpha-GalNAc,VIII(2)-alpha-Fuc,IV(6)-beta-[GalNAc-alpha-(1->3)-(Fuc-alpha-(1->2))-Gal-beta-(1->4)-GlcNAc]-nLc8Cer(d20:1(4E))
- blood group type II chain A(d) (d20:1(4E))
- N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-alpha-D-galactosaminyl-(1->3)-(alpha-L-fucosyl-(1->2))-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acyl-eicosasphing-4-enine
- N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-alpha-D-galactosaminyl-(1->3)-(alpha-L-fucosyl-(1->2))-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acyl-icosasphingosine
URI
http://www.irandoc.acir/onto/irandoc/CHEBI:145141
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}

